ProMIS Neurosciences, Inc. announced a non-brokered private placement for gross proceeds of CAD 24,710,516 on August 25, 2021. The company will issue units in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. Each unit consist of one common share and one share purchase warrant. Each warrant will entitle the holder to purchase one additional common share at an exercise price of CAD 0.21 per common share until August 25, 2026.